What's New in SCLC? A Review

by Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Corey A. Carter
Published 2017-10-01

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine

by Bryan Oronsky, Harry E. Gruber, Wendy Reiners, Tony R. Reid
Published 2021-03-01

A Review of Newly Diagnosed Glioblastoma

by Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Navjot Sandhu, Susan J. Knox
Published 2021-02-01

RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

by Bryan Oronsky, Corey A. Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky, Tony R. Reid
Published 2020-01-01

Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer

by Bryan Oronsky MD, Chris Larson MD, PhD, Tony R. Reid MD, PhD, Corey A. Carter MD
Published 2018-07-01

Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review

by Bryan Oronsky, Patrick Ma, Tony R. Reid, Pedro Cabrales, Michelle Lybeck, Arnold Oronsky, Neil Oronsky, Corey A. Carter
Published 2018-01-01

Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets

by Corey A. Carter, Bryan Oronsky, Scott Caroen, Jan Scicinski, Aiste Degesys, Pedro Cabrales, Tony R. Reid, Christina Brzezniak
Published 2016-05-01

A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)

by Christopher Larson, Bryan Oronsky, Gina Varner, Scott Caroen, Erica Burbano, Elisa Insel, Farah Hedjran, Corey A. Carter, Tony R. Reid
Published 2018-09-01

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance

by Bryan Oronsky, Corey A. Carter, Tony R. Reid, Jan Scicinski, Arnold Oronsky, Michelle Lybeck, Scott Caroen, Meaghan Stirn, Neil Oronsky, Peter Langecker
Published 2015-09-01

No patient left behind: The promise of immune priming with epigenetic agents

by Corey A. Carter, Bryan T. Oronsky, Joseph Roswarski, Arnold L. Oronsky, Neil Oronsky, Jan Scicinski, Harry Lybeck, Michelle M. Kim, Michelle Lybeck, Tony R. Reid
Published 2017-10-01

Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

by Corey A. Carter, Bruno Schmitz, P. Gabriel Peterson, Mary Quinn, Aiste Degesys, John Jenkins, Bryan Oronsky, Jan Scicinski, Scott Caroen, Tony R. Reid, Pedro Cabrales, Christina Brzezniak
Published 2016-03-01

Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

by Bryan Oronsky, Jan Scicinski, Michelle M. Kim, Pedro Cabrales, Michael E. Salacz, Corey A. Carter, Neil Oronsky, Harry Lybeck, Michelle Lybeck, Christopher Larson, Tony R. Reid, Arnold Oronsky
Published 2016-07-01

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001

by Bryan Oronsky, Scott Caroen, Karen Zeman, Mary Quinn, Christina Brzezniak, Jan Scicinski, Pedro Cabrales, Tony R. Reid, Jane B. Trepel, Nacer D. Abrouk, Christopher Larson, Arnold Oronsky, Harry E. Lybeck, Regina M. Day, Corey A. Carter
Published 2016-11-01

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient after Priming with RRx-001

by Bryan Oronsky, Scott Caroen, Karen Zeman, Mary Quinn, Christina Brzezniak, Jan Scicinski, Pedro Cabrales, Tony R. Reid, Jane B. Trepel, Nacer D. Abrouk, Christopher Larson, Arnold Oronsky, Harry E. Lybeck, Regina M. Day, Corey A. Carter
Published 2016-01-01

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor

by Christina Brzezniak, Bryan Oronsky, Jane Trepel, Thomas A. Summers Jr., Pedro Cabrales, Min-Jung Lee, Regina Day, Saheli Jha, Scott Caroen, Karen Zeman, Lindsey Ferry, Cindy Harmer, Neil Oronsky, Michelle Lybeck, Harry E. Lybeck, James F. Brown, Tony R. Reid, Corey A. Carter
Published 2017-03-01